Legal & General Group Plc - SCICLONE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$1,056,000
+1.4%
94,464
-0.1%
0.00%0.0%
Q2 2017$1,041,000
+28.7%
94,599
+14.4%
0.00%0.0%
Q1 2017$809,000
-9.6%
82,667
-0.3%
0.00%0.0%
Q4 2016$895,000
+102.9%
82,891
+91.4%
0.00%
Q3 2016$441,000
+293.8%
43,314
+400.2%
0.00%
Q2 2016$112,000
+23.1%
8,6600.0%0.00%
Q1 2016$91,000
+9.6%
8,660
-4.9%
0.00%
Q4 2015$83,000
+31.7%
9,1020.0%0.00%
Q3 2015$63,000
-26.7%
9,1020.0%0.00%
Q2 2015$86,000
+7.5%
9,1020.0%0.00%
Q1 2015$80,0000.0%9,1020.0%0.00%
Q4 2014$80,000
+19.4%
9,102
-6.3%
0.00%
Q3 2014$67,0009,7150.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Sensato Investors LLC 1,564,682$10,859,0002.03%
Matarin Capital Management, LLC 274,291$1,903,580,0000.39%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 87,524$607,417,0000.36%
TFS CAPITAL LLC 323,415$2,245,0000.22%
Nantahala Capital Management 170,218$1,181,0000.16%
Ativo Capital Management LLC 74,338$592,0000.16%
MENTA CAPITAL LLC 111,985$777,0000.12%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 229,891$1,595,0000.11%
GSA CAPITAL PARTNERS LLP 270,888$1,880,0000.09%
BOOTHBAY FUND MANAGEMENT, LLC 25,644$178,0000.08%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders